Sudden-Onset Polyposis in Pediatric Patients With Ulcerative Colitis

2022 ◽  
Author(s):  
Soon Chul Kim
Keyword(s):  
Ulcerative Colitis ◽  
Pediatric Patients ◽  
Sudden Onset

Sigmoid Volvulus in 16-year-old Boy with an Associated Anomalous Congenital Band

2013 ◽  
Vol 79 (11) ◽  
pp. 1140-1141 ◽  
Author(s):  
Ann A. Albert ◽  
Tracy L. Nolan ◽  
Bryan C. Weidner
Keyword(s):  
Abdominal Pain ◽  
African American Male ◽  
Pediatric Patients ◽  
Primary Anastomosis ◽  
Exploratory Laparotomy ◽  
Sigmoid Volvulus ◽  
Sudden Onset ◽  
Contrast Enema ◽  
Pediatric Age Group ◽  
History Of

Sigmoid volvulus, a condition generally seen in debilitated elderly patients, is extremely rare in the pediatric age group. Frequent predisposing conditions that accompany pediatric sigmoid volvulus include intestinal malrotation, omphalomesenteric abnormalities, Hirschsprung's disease, imperforate anus and chronic constipation. A 16-year-old previously healthy African American male presented with a 12 hour history of sudden onset abdominal pain and intractable vomiting. CTwas consistent with sigmoid volvulus. A contrast enema did not reduce the volvulus, but it was colonoscopically reduced. Patient condition initially improved after colonoscopy, but he again became distended with abdominal pain, so he was taken to the operating room. On exploratory laparotomy, a band was discovered where the mesenteries of the sigmoid and small bowel adhered and created a narrow fixation point around which the sigmoid twisted. A sigmoidectomy with primary anastomosis was performed. The diagnosis of sigmoid volvulus may be more difficult in children, with barium enema being the most consistently helpful. Seventy percent of cases do not involve an associated congenital problem, suggesting that some pediatric patients may have congenital redundancy of the sigmoid colon and elongation of its mesentery. The congenital band found in our patient was another potential anatomic factor that led to sigmoid volvulus. Pediatric surgeons, accustomed to unusual problems in children, may thus encounter a condition generally found in the debilitated elderly patient.

Does the timing of pouch creation in 2-stage operations for pediatric patients with ulcerative colitis matter?

2021 ◽  
Author(s):  
Nathan S. Rubalcava ◽  
Natalie A. Moreno ◽  
Jeremy Adler ◽  
James D. Geiger ◽  
Ronald B. Hirschl ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Pediatric Patients

THE CUMULATIVE INCIDENCE OF POUCHITIS AND POUCH-RELATED COMPLICATIONS IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS

2021 ◽  
Vol 160 (3) ◽  
pp. S2
Author(s):  
Ellen Cowherd ◽  
Matthew Egberg ◽  
Michael Kappelman ◽  
Xian Zhang ◽  
Millie Long ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Cumulative Incidence ◽  
Pediatric Patients

scholarly journals Clinical and Pathologic Remission of Pediatric Ulcerative Colitis with Serum-Derived Bovine Immunoglobulin Added to the Standard Treatment Regimen

2017 ◽  
Vol 11 (2) ◽  
pp. 335-343 ◽  
Author(s):  
Rachelle A. Soriano ◽  
Asuncion G. Ramos-Soriano
Keyword(s):  
Ulcerative Colitis ◽  
Treatment Regimen ◽  
Pediatric Patients ◽  
Opportunistic Infections ◽  
Activity Index ◽  
Mucosal Healing ◽  
Chronic Inflammatory Bowel Disease ◽  
Medical Food ◽  
Markers Of Inflammation ◽  
Bovine Immunoglobulin

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is particularly troublesome for pediatric patients, as current therapeutic options consist of biologic agents and steroids which alter the immune response and have the harmful side effect of leaving the patient more susceptible to opportunistic infections and eventual surgery. Another option for therapy exists in the form of serum-derived bovine immunoglobulin/protein isolate (SBI), the key ingredient in a medical food, EnteraGam®. The FDA has reviewed the safety of SBI and issued a no challenge letter to the generally recognized as safe (GRAS) findings for this medical food. The product also has no known food or drug interactions, no significant adverse effects, and no contraindications, save for beef allergy. SBI has been shown to induce clinical remission in adult populations and to decrease markers of inflammation in pediatric patients. Here, we present a detailed case of pediatric UC, including documentation of mucosal healing and decrease in pediatric UC activity index in a difficult to treat pediatric patient, after the addition of SBI to this patient’s treatment regimen.

scholarly journals Sa1899 – Fibrosis in Pediatric Patients with Ulcerative Colitis is Linked to Chronicity and Severity of Inflammation

2019 ◽  
Vol 156 (6) ◽  
pp. S-446
Author(s):  
Suha Abushamma ◽  
Jacob A. Kurowski ◽  
Ren Mao ◽  
Satya Kurada ◽  
Amandeep Singh ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Pediatric Patients

Microbial Dysbiosis Associated with Disease Severity in Treatment Naive Pediatric Patients with New-Onset Ulcerative Colitis

2017 ◽  
Vol 152 (5) ◽  
pp. S172-S173
Author(s):  
Melanie Schirmer ◽  
Hera Vlamakis ◽  
Lee A. Denson ◽  
Sonia Davis ◽  
Paul A. Rufo ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Disease Severity ◽  
Pediatric Patients ◽  
Microbial Dysbiosis ◽  
Treatment Naïve ◽  
New Onset

Su2022 - Evaluation of Adalimumab Effectiveness in Pediatric Patients with Ulcerative Colitis in Clinical Practice

2018 ◽  
Vol 154 (6) ◽  
pp. S-668-S-669 ◽  
Author(s):  
Steven J. Steiner ◽  
Chunyan Liu ◽  
Eileen King ◽  
Esther Israel ◽  
Brad Pasternak ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Clinical Practice ◽  
Pediatric Patients

Comparison of Radiologic Studies in Pediatric Patients with Crohn Disease and Ulcerative Colitis

2008 ◽  
Vol 103 ◽  
pp. S535-S536
Author(s):  
Deborah Flomenhoft ◽  
Joseph Auer ◽  
Houssam Mardini ◽  
Harohalli Shashidhar ◽  
Willem De Villiers
Keyword(s):  
Ulcerative Colitis ◽  
Crohn Disease ◽  
Pediatric Patients
Sign in / Sign up

Export Citation Format

Share Document